Reassuring evidence on infection risk with dupilumab in atopic dermatitis: Lessons from real-world evidence

^*Corresponding author for this work

Research output: Contribution to journal › Comment/Letter to the editor › Academic

Original language	English
Pages (from-to)	2026-2027
Number of pages	2
Journal	JEADV : journal of the European Academy of Dermatology and Venereology
Volume	39
Issue number	12
DOIs	https://doi.org/10.1111/jdv.70114
Publication status	Published - Dec 2025

Access to Document

@article{d34a32a2fec5495b972e39b810f3995e,

title = "Reassuring evidence on infection risk with dupilumab in atopic dermatitis: Lessons from real-world evidence",

author = "\{van der Gang\}, \{Lian F\} and \{de Bruin-Weller\}, \{Marjolein S\}",

year = "2025",

month = dec,

doi = "10.1111/jdv.70114",

language = "English",

volume = "39",

pages = "2026--2027",

journal = "JEADV : journal of the European Academy of Dermatology and Venereology",

issn = "0926-9959",

publisher = "Wiley-Blackwell",

number = "12",

}

TY - JOUR

T1 - Reassuring evidence on infection risk with dupilumab in atopic dermatitis

T2 - Lessons from real-world evidence

AU - van der Gang, Lian F

AU - de Bruin-Weller, Marjolein S

PY - 2025/12

Y1 - 2025/12

U2 - 10.1111/jdv.70114

DO - 10.1111/jdv.70114

M3 - Comment/Letter to the editor

C2 - 41287445

SN - 0926-9959

VL - 39

SP - 2026

EP - 2027

JO - JEADV : journal of the European Academy of Dermatology and Venereology

JF - JEADV : journal of the European Academy of Dermatology and Venereology

IS - 12

ER -